BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Doxycycline
,
rs4950928
,
TGFB1
,
Angiogenesis
,
Influenza
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Mcl-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Leukocyte (polymorphonuclear) of peripheral blood
Neutrophil of bone marrow
Dendritic (plasmacytoid) cell
Mononuclear cell of peripheral blood
T Lymphocyte (regulatory) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vaccination status
Renal interstitial fibrosis
Irritable bowel syndrome
Interstitial lung disease
Bronchitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
pirenperone
Flufenamic Acid
Pentamidine
myosmine
ethaverine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Gjd2
ZYX
OLR1
MVK
Mir181b1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative …
Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Al…
Targeting MCL-1 in hematologic malignancies: Rationale and progress.
PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 d…
Requirement for antiapoptotic MCL-1 during early erythropoiesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Mult…
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/M…
Avo In R/R And Previously Untreated MCL
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ